Just did some research on BPMX’ behavior of releasing clinical trial data after study completion dates. Usually, the company releases study data within 3-5 weeks after the completion date.
Study: BPX-01 Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Study Start Date: August 2016 Actual Study Completion Date: March 24, 2017 Last Update Posted: April 14, 2017
Official announcement by BPMX on May 3, 2017:
“BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for Acne”
About 4 weeks after the completion date, the company released the study results.
Current studies, where results should be released within a few days/weeks.
BPX-01 Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris.
The study has been marked as completed on June 1, 2018. Given BPMX’ history of releasing study data within 3-5 weeks after the completion date, we should see an official release in the next days.
There is also an “Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)“ with an estimated completion date on June 30, 2018. I expect study results within July Q2.
Btw, this is KingBiotech. I'm just using another account!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.